| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/12/1994 | US5302697 For controlling secretion of proteins or peptides by genetically engineered saccharomyces culture products |
| 04/12/1994 | US5302582 Enkastins: new glycopeptides which act to inhibit enkephlinase, processes for their preparation, and their use as pharmaceutical products |
| 04/12/1994 | US5302581 Administering with lipids for the treatment of respiratory disease |
| 04/12/1994 | US5302532 Containing flocculant |
| 04/12/1994 | US5302530 DNA coding for an antigen of Blastomyces dermatitidis |
| 04/12/1994 | US5302526 Recombinant DNA enclosed amphiphilic leader sequences for the production and purification of fusion proteins |
| 04/12/1994 | US5302519 Genetic engineering |
| 04/12/1994 | US5302518 In the presence of a heat shock protein |
| 04/12/1994 | US5302516 Catalytic and reactive polypeptides and methods for their preparation and use |
| 04/12/1994 | US5302511 Antibodies to peptides unique to specific keratin proteins |
| 04/12/1994 | US5302507 Antigenic peptide for detecting anti-hepatitis C virus antibodies and use thereof |
| 04/12/1994 | US5302387 Bacillus thuringiensis isolates active against cockroaches and genes encoding cockroach-active toxins |
| 04/12/1994 | US5302384 Administering to treat inflammation |
| 04/12/1994 | US5302370 Form complexes with rhenium and technetium |
| 04/12/1994 | US5302360 Adding elemental antimony to inactivated antimony pentahalide catalyst solution to yield antimony trihalide; crystallization; separation of impurities; halogenation |
| 04/12/1994 | CA1328540C Cyclic anticoagulant peptides |
| 04/12/1994 | CA1328419C Receptors for efficient determination of ligands and their antagonists or agonists |
| 04/12/1994 | CA1328402C Somatostatins |
| 04/10/1994 | CA2108112A1 Process for making pathogen-resistant plants |
| 04/09/1994 | CA2566574A1 Fibrin sealant compositions and method for utilizing same |
| 04/08/1994 | CA2107761A1 Human monoclonal anti-peptide antibody and dna encoding thereof |
| 04/07/1994 | DE4233646A1 New HIV-type immune deficiency virus ECACC V 92092318 |
| 04/07/1994 | CA2079983A1 Isolated mink growth hormone genes, novel recombinant dna and methods for producing mink growth hormone |
| 04/06/1994 | EP0590747A2 A novel-beta1- 6 N-acetylglucosaminyltransferase, its acceptor molecule, leukosialin, and a method for cloning proteins having enzymatic activity |
| 04/06/1994 | EP0590721A1 Method for expressing receptors of the human nervous system in the yeast Schizosaccharomyces pombe |
| 04/06/1994 | EP0590707A1 Transformation of Phaffia Rhodozyma |
| 04/06/1994 | EP0590689A2 Method for obtaining DNA, RNA, peptides, polypeptides or proteins by means of a DNA-recombinant technique |
| 04/06/1994 | EP0590530A2 Fusion proteins for prodrug-activation |
| 04/06/1994 | EP0590301A2 Method for protecting plants from disease and infestation by gene insertion, and vectors and plant cells containing said genes |
| 04/06/1994 | EP0590156A1 Novel, physiologically active protein and hemopoietic stem cell growth promoter |
| 04/06/1994 | EP0590126A1 Polypeptides having kinase activity, their preparation and use |
| 04/06/1994 | EP0590090A1 SELECTIVE INHIBITION OF LEUKEMIC CELL PROLIFERATION BY $i(BCR-ABL) ANTISENSE OLIGONUCLEOTIDES |
| 04/06/1994 | EP0590082A1 Antisense oligonucleotide inhibition of the ras gene |
| 04/06/1994 | EP0590076A1 Production of human hemoglobin in transgenic pigs |
| 04/06/1994 | EP0590071A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-$g(b)1 BINDING MOLECULES AND USES THEREOF |
| 04/06/1994 | EP0590059A1 Production and recovery of recombinant neurotrophins |
| 04/06/1994 | EP0590058A1 Method for making humanized antibodies |
| 04/06/1994 | EP0590057A1 MIMIC PEPTIDES OF gp120 |
| 04/06/1994 | EP0590055A1 M-protein peptides of influenza virus as antiviral agents |
| 04/06/1994 | EP0590051A1 Intercellular adhesion molecule-3 and its binding ligands |
| 04/06/1994 | EP0590048A1 Therapeutic fragments of von willebrand factor |
| 04/06/1994 | EP0590044A1 Composition and treatment with biologically active peptides having c-terminal substitutions |
| 04/06/1994 | EP0590030A1 A receptor-type tyrosine kinase [human eph/elk-like kinase - hek] and use thereof |
| 04/06/1994 | EP0590027A1 Insertional mutations in mycobacteria |
| 04/06/1994 | EP0590011A1 Abrin variants and immunnotoxins |
| 04/06/1994 | EP0590006A1 Synthetic pulmonary surfactant peptides |
| 04/06/1994 | EP0590004A1 Purified chitinases and use thereof |
| 04/06/1994 | EP0589995A1 Novel polypeptides and their use |
| 04/06/1994 | EP0589993A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 04/06/1994 | EP0589989A1 USE OF $g(b)-CELL TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF HYPERINSULINAEMIA AND ASSOCIATED DISEASES |
| 04/06/1994 | EP0589961A1 Assay systems for neurotrophin activity |
| 04/06/1994 | EP0589955A1 Medicinal use of jacaline and fragments thereof, in particular for treating hiv-related diseases |
| 04/06/1994 | EP0589943A1 Mycobacterium proteins and applications |
| 04/06/1994 | EP0589930A1 GABA-A RECEPTOR SUBUNITS ($g(a)-2, $g(a)-3, $g(a)-5, $g(a)-6, $g(b)-2) AND TRANSFECTED CELLS EXPRESSING THEM |
| 04/06/1994 | EP0589928A1 Cold tolerances in plants |
| 04/06/1994 | EP0589894A1 Insecticidally effective peptides |
| 04/06/1994 | EP0589875A1 Immune system stabilizers for prevention and therapy of disorders associated with immune system dysfunction |
| 04/06/1994 | EP0512011B1 Recombinantly produced blood factors and process for the expression of said blood factors, as well as vaccinia virus recombinants used in said process |
| 04/06/1994 | EP0489116B1 Fusion proteins comprising gm-csf and il-3 |
| 04/06/1994 | EP0432256B1 Improved biological insect control agents and methods of use |
| 04/06/1994 | EP0418297B1 Pharmaceutical compositions and use thereof in treating inflammation |
| 04/06/1994 | EP0383856B1 Use of peptides for inhibiting blood vessel blockage |
| 04/06/1994 | EP0353295B1 Novel and improved antibodies for site specific attachment of compounds |
| 04/06/1994 | EP0295285B1 Method for the production of bovine growth hormone using a synthetic gene |
| 04/06/1994 | EP0229126B1 Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for purification, removal, inhibition or assay of the inhibitors |
| 04/06/1994 | CN1084889A Trichosanthes kirilowii protein synthetic genes |
| 04/06/1994 | CN1084855A PFEMP3 malaria antigen, analogs, antibodies and uses thereof |
| 04/06/1994 | CN1084849A Dual action inhibitors |
| 04/05/1994 | US5300651 Indole NH-group blocked with tert-butoxycarbonyl, a-amino group with 9-fluoroenzylmethoxycarbonyl |
| 04/05/1994 | US5300632 Method for purifying an outer membrane protein of Haemophilus influenzae |
| 04/05/1994 | US5300631 Antibodies specific for either ras photo-oncogene encoded P21 proteins or ras oncogene encoded P21 proteins but not for both and method of producing same |
| 04/05/1994 | US5300629 Bactericidal and/or bacteriostatic peptides isolated from hemolymph of honeybees |
| 04/05/1994 | US5300490 Anticoagulant substance obtained from urine |
| 04/05/1994 | US5300434 Determing collagen degradation in vivo |
| 04/05/1994 | US5300433 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 04/05/1994 | US5300278 Binding antibodies |
| 04/05/1994 | CA1328333C Amino acid derivatives |
| 04/05/1994 | CA1328332C Peptide boronic acid inhibitors of trypsin-like proteases |
| 04/05/1994 | CA1328239C Bacillus thuringiensis strain, method for their isolation and related insecticidal compositions |
| 04/05/1994 | CA1328237C Bioadhesives for cell and tissue adhesion |
| 04/05/1994 | CA1328236C Plant tissue transformation |
| 04/02/1994 | CA2107279A1 Dictyostelium dipeptidylaminopeptidase |
| 03/31/1994 | WO1994007143A1 Diagnosis of autosomal muscular dystrophy |
| 03/31/1994 | WO1994006921A1 Recombinant retroviral vector against felv and/or fiv |
| 03/31/1994 | WO1994006918A2 Transformation of phaffia rhodozyma |
| 03/31/1994 | WO1994006917A1 Production of desired proteins or polypeptides by culturing a transformed lactic acid bacterium |
| 03/31/1994 | WO1994006916A1 Gene transcription and ionizing radiation: methods and compositions |
| 03/31/1994 | WO1994006913A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 03/31/1994 | WO1994006912A1 Epstein-barr virus peptides and antibodies against these peptides |
| 03/31/1994 | WO1994006911A2 Mycoplasma pulmonis antigens and methods and compositions for use in cloning and vaccination |
| 03/31/1994 | WO1994006910A1 Gene therapy by retroviral vector with tumor suppressive gene |
| 03/31/1994 | WO1994006909A2 A method of preventing tumor metastasis |
| 03/31/1994 | WO1994006908A1 Transgenic non-human animals having targeted lymphocyte transduction genes |
| 03/31/1994 | WO1994006904A1 Novel infectious bursal disease virus |
| 03/31/1994 | WO1994006903A1 Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes |
| 03/31/1994 | WO1994006830A1 Fibrinogen binding protein |
| 03/31/1994 | WO1994006829A1 Basophil granule proteins |
| 03/31/1994 | WO1994006828A1 Peptides tolerizing t-cells and compositions thereof |
| 03/31/1994 | WO1994006827A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 03/31/1994 | WO1994006826A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis |